| Application no. and date | 16020363.4 (espacenet) (Federated) (European Patent Register), 20110128 | | Patent/reg. no. and date | DK/EP 3158991, 20210317 | | Publication date | 20170426 | | Priority no. and date | US 299100 P, 20100128 | | EP pub. no. and date |
EP 3158991 20170426 | | Effective date | | | Applicant/owner | Eagle Pharmaceuticals, Inc., 50 Tice Boulevard
Woodcliff Lake, NJ 07677, US | | Applicant ref. no. | P76919DK01 | | Inventor | PALEPU, Nagesh R., 30 Addis Drive
Southampton, Pennsylvania 18966, US,
BUXTON, Philip Christopher, 11 Bradley Close
Great Dunmow, Essex CM6 2PB, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 47/10 (2017.01) , A61K 47/20 (2006.01) , A61K 9/08 (2006.01) , A61P 35/00 (2006.01) | | Title | FORMULERINGER AF BENDAMUSTIN | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
